As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of DarioHealth Corp. The largest reported stake is Nantahala Capital Management, LLC's, at 9.99%. 9 filings are on record since July 18, 2025 (Schedule 13G/A, February 13, 2026).
Sell to companies like DarioHealth Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Nantahala Capital Management, LLC · Sole voting: 0 · Shared voting: 688,673 · Sole dispositive: 0 · Shared dispositive: 688,673 · SCHEDULE 13G/A, 2026-02-13
- · Reporting person: Craig Kallman 2015 Living Trust · Sole voting: 0 · Shared voting: 675,165 · Sole dispositive: 0 · Shared dispositive: 675,165 · SCHEDULE 13G, 2025-12-16
- · Reporting person: Nantahala Capital Partners Limited Partnership · Sole voting: 0 · Shared voting: 316,497 · Sole dispositive: 0 · Shared dispositive: 316,497 · SCHEDULE 13G/A, 2025-11-14
- · Holder: Nantahala Capital Management, LLC · Percent: 9.99% · SCHEDULE 13G/A
- · Holder: Tasso Partners, LLC · Percent: 9.99% · SCHEDULE 13G/A
DarioHealth Corp. has 9 Schedule 13D or 13G filings on record since 2025-07-18. 3 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 688,673 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Tasso Partners, LLC | 9.99% | 676,141 | SCHEDULE 13G/A, 2025-11-12 | 2025-09-30 |
| Craig Kallman 2015 Living Trust | 9.99% | 675,165 | SCHEDULE 13G, 2025-12-16 | 2025-09-23 |
| Nantahala Capital Partners Limited Partnership | 4.59% | 316,497 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Titan Trust 2024 I | 0% | 0 | SCHEDULE 13G/A, 2025-10-09 | 2025-09-30 |
Holding shares or following this stake? See who's behind DarioHealth Corp. and the warning signs.
Free to see. No signup.
Keep reading
More on DarioHealth Corp. and the records around it.
The people at DarioHealth Corp.
- Dennis McGrath is also named on 12 other Form D filings: PAVmed Inc. (Feb 2026), Veris Health Inc. (Jul 2025)
- Hila Karah is also named on 9 other Form D filings: Indaptus Therapeutics, Inc. (Jun 2025)
DarioHealth Corp. elsewhere on the record
- Leadership changes Sep 2026
- Form D filing Oct 2025
- Who owns it
Companies that share a holder
- Craig Kallman 2015 Living Trust also filed stake reports on 1 other company: PAVmed Inc. (Oct 2026)
- Tasso Partners, LLC also filed stake reports on 2 other companies: PAVmed Inc. (Apr 2026), Orchestra BioMed Holdings, Inc. (Nov 2025)
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP also filed stake reports on 6 other companies: FEMASYS INC. (Aug 2026), AZITRA, INC. (Aug 2026), ABEONA THERAPEUTICS INC. (May 2026)
Watch DarioHealth Corp.
Get an email when DarioHealth Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on DarioHealth Corp.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DarioHealth Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DarioHealth Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 0 | 688,673 | 0 | 688,673 | SCHEDULE 13G/A, 2026-02-13 |
| Wilmot B. Harkey | 0 | 688,673 | 0 | 688,673 | SCHEDULE 13G/A, 2026-02-13 |
| Daniel Mack | 0 | 688,673 | 0 | 688,673 | SCHEDULE 13G/A, 2026-02-13 |
| Craig Kallman 2015 Living Trust | 0 | 675,165 | 0 | 675,165 | SCHEDULE 13G, 2025-12-16 |
| Craig Kallman | 0 | 675,165 | 0 | 675,165 | SCHEDULE 13G, 2025-12-16 |
| Nantahala Capital Partners Limited Partnership | 0 | 316,497 | 0 | 316,497 | SCHEDULE 13G/A, 2025-11-14 |
The latest filing names DarioHealth Corp., with its principal executive office as 322 W 57TH ST. #33B, NEW YORK, NY 10019 (SCHEDULE 13G/A, 2026-02-13).
What the percentages are based on
As of September 30, 2025, each of the Reporting Persons may be deemed to be the beneficial owner of 4.5912% of the total number of Shares outstanding, based on 6,768,184 shares outstanding received from the Issuer on October 29, 2025.Nantahala Capital Partners Limited Partnership, SCHEDULE 13G/A, 2025-11-14
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-18 | Titan Trust 2024 I | 0% | SCHEDULE 13G/A |
| 2025-07-22 | Titan Trust 2024 I | 5.32% | SCHEDULE 13G |
| 2025-08-14 | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G/A |
| 2025-10-09 | Titan Trust 2024 I | 0% | SCHEDULE 13G/A |
| 2025-11-12 | Tasso Partners, LLC | 9.99% | SCHEDULE 13G/A |
| 2025-11-14 | Nantahala Capital Partners Limited Partnership | 4.59% | SCHEDULE 13G/A |
| 2025-11-14 | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G/A |
| 2025-12-16 | Craig Kallman 2015 Living Trust | 9.99% | SCHEDULE 13G |
| 2026-02-13 | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G/A |
Questions about who owns DarioHealth Corp.
Who owns DarioHealth Corp.?
On this page, 3 holders' latest ownership filings report 5% or more of DarioHealth Corp.: Nantahala Capital Management, LLC (9.99%, Schedule 13G/A, filed 2026-02-13), Tasso Partners, LLC (9.99%, Schedule 13G/A, filed 2025-11-12) and Craig Kallman 2015 Living Trust (9.99%, Schedule 13G, filed 2025-12-16).
Who are the largest shareholders of DarioHealth Corp.?
By the share each holder's latest filing reports, the largest holders of DarioHealth Corp. on this page are Nantahala Capital Management, LLC (9.99%), Tasso Partners, LLC (9.99%) and Craig Kallman 2015 Living Trust (9.99%).
When did Nantahala Capital Management, LLC buy into DarioHealth Corp.?
The filings give report dates, not purchase dates. The earliest filing from Nantahala Capital Management, LLC on this page is the Schedule 13G/A, filed 2025-08-14, reporting 9.99%; its latest, Schedule 13G/A filed 2026-02-13, reports 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for DarioHealth Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 4, 2026 | Leadership change: Lawrence Leisure departs | — | Leadership changes | Source |
| April 13, 2026 | Leadership change: John R. Palumbo appointed, Director | — | Leadership changes | Source |
| October 7, 2025 | Form D, private offering | $17.50M sold | Form D page | Source |
| January 17, 2025 | Form D, private offering | $18.80M sold | Form D page | Source |
| January 17, 2025 | Form D, private offering | $6.80M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for DarioHealth Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.